Clinical Trial

A Study to Monitor Safety and Effectiveness of Approved J&J MedTech Devices in the Treatment of Participants With Ischemic Stroke

Study acronym: POSEIDON
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to collect medical information to monitor the ongoing safety of the J\&J MedTech devices and to understand how well they work when routinely used to treat participants with acute ischemic stroke (a condition caused by a blocked blood vessel in the brain).
Trial Details
NCT Number NCT07760649
Lead Sponsor Neuravi Limited
Conditions Ischemic Stroke
Enrollment 5,000 participants
Start Date 2026-08-10
Primary Completion 2030-10-16 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12